• July 2009

Imaging3 to Host "State of the Company" Conference Call

Burbank, CA – July 3, 2009 – Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced today that on Monday, July 6, 2009 at 11:00am PDT, the company’s CEO, Mr. Dean Janes, will be hosting a conference call to provide an update on the company’s plans as well as an update on FDA approval progress.

To join the conference call, please call 1-866-212-0875 and enter passcode 172951 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation. A recording of the conference call will also be available on the company’s website following the conference.

If you have any questions, please feel free to contact me by e-mail or directly by calling (800) 900-9729.

Sincerely,

Mike Nessen
Vice President Business Development
Imaging3, Inc.
Burbank CA 91505
(800) 900-9729
mike@imaging3.com
www.imaging3.com



Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.